Return to homepagePandemic Pact

MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR): SARS-CoV-2 VACCINE RESEARCH RELATED ACTIVITIES

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 272201600013C-P00026-9999-13

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $443,137

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    TIMOTHY STEDMAN

  • Research Location

    United States of America

  • Lead Research Institution

    AMERICAN TYPE CULTURE COLLECTION

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This contract provides unique and quality-assured infectious reagents and resources to the scientific community for use in basic research and product development. The scope of this contract includes the acquisition, authentication, production, preservation, storage, and distribution of research and reference reagents to the research community. These reagents span the pathogens in the Division of Microbiology and Infectious Diseases portfolio, and include the National Institutes of Allergy and Infectious Disease (NIAID) Category A, B and C Priority Pathogens and emerging infectious diseases.